Jave-Suárez LF

ORCID: 0000-0001-6209-5031 · 2 papers in corpus

2026

Discovery and Development of a TGFβ3/IL-13 Plasma Risk Score for Preoperative Discrimination of Benign and Malignant Ovarian Adnexal Masses.

Diagnostics (Basel, Switzerland) ·doi:10.3390/diagnostics16152365

Background/Objectives: Differentiating between benign and malignant ovarian adnexal masses before surgery is a significant diagnostic challenge. This study examined a wide range of circulating plasma molecules (immune and inflammatory) to i…

2025

Utility of a Multimodal Biomarker Panel and Serum Proapoptotic Activity to Refine Diagnosis of Ovarian Adnexal Masses.

Diseases (Basel, Switzerland) ·doi:10.3390/diseases13100342

Background/objectivesOvarian adnexal masses present diagnostic challenges due to their heterogeneous etiologies. Accurately differentiating these conditions is critical for timely and effective clinical intervention. This study evaluated ci…